Research Reflections: Coombs Provides Insight Into Key ASH Abstracts in CLL

Season 6 Episode 26  ·  Jan 17, 2022, 08:56 PM

Headliner
Share
Subscribe

Dr Coombs discusses research that was presented at the 2021 ASH Annual Meeting and Exposition in chronic lymphocytic leukemia, including that with covalent and noncovalent BTK inhibitors, COVID-19 vaccinations, and time-limited combinations.

Share
Subscribe
Next
Wang Reflects on Ibrutinib’s Role and Emerging Research in MCL Management
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air